Abstract. Mycobacterium chimaera is an opportunistic environmental mycobacterium, belonging 22 to the Mycobacterium intracellulare complex. Although most commonly associated with 23 pulmonary disease, there has been growing awareness of invasive M. chimaera infections following 24 cardiac surgery. Investigations suggest world-wide spread of a specific M. chimaera clone, 25 associated with contaminated hospital heater-cooler units used during the surgery. Given the global 26 dissemination of this clone, its potential to cause invasive disease, and the laboriousness of current 27 culture-based diagnostic methods, there is a pressing need to develop rapid and accurate diagnostic 28 assays, specific for M. chimaera. Here, we assessed 354 mycobacterial genome sequences and 29 confirmed that M. chimaera is a phylogenetically coherent group. In silico comparisons indicated 30 six DNA regions present only in M. chimaera. We targeted one of these regions and developed a 31
TaqMan qPCR assay for M. chimaera with a detection limit of 10 CFU in whole blood. In vitro 32 screening against DNA extracted from 40 other mycobacteria and 22 bacterial species from 21 33 diverse genera confirmed in silico predicted specificity for M. chimaera. Screening 33 water 34 samples from heater cooler units with this assay highlighted the increased sensitivity of PCR 35 compared to culture, with 15 of 23 culture negative samples positive by M. chimaera qPCR. We 36 have thus developed a robust molecular assay that can be readily and rapidly deployed to screen 37 clinical and environmental specimens for M. chimaera. 38 39
Introduction. 40
Mycobacterium chimaera is an environmental mycobacterium and infrequent pathogen, most 41 commonly linked with pulmonary disease (1) (2) (3) (4) (5) (6) (7) (8) . Interest in M. chimaera has heightened with global 42 reports of invasive infections (including endocarditis and vascular graft infections associated with 43 the use of LivaNova PLC (formerly Sorin Group Deutschland GmbH) Stöckert 3T heater-cooler 44 units during cardiac surgery. The most plausible hypothesis for this widespread contamination is a 45 point-source outbreak, although the underlying causative factors are not currently known (9) (10) (11) (12) (13) (14) (15) (16) . 46
Phylogenetic comparisons of 16S-23S rRNA internal transcribed spacer (ITS) sequences, and/or 47 partial rpoB or hsp65 sequences (2, 5-7, 17, 18) suggest M. chimaera as a distinct entity within the 48 M. intracelluare complex (6) and two recent population genomic analyses have confirmed this 49 relationship (8, 13). The complete 6,593,403 bp genome sequence of M. chimaera ANZ045 50 revealed a single circular 6,078,672 bp chromosome and five circular plasmids ranging in size from 51 21,123 bp to 324,321 (8) . M. chimaera is slow-growing, therefore current culture-based laboratory 52 methods, followed by Sanger sequencing of amplicons for one or more combinations of conserved 53 sequence regions, or line-probe hybridization assays are not amenable to timely and specific 54 detection of this pathogen. This delay carries significant clinical, health provision, and medico-55 legal implications as patients may be exposed to contaminated machines during this turn-around 56 time of up to 6-8 weeks. A rapid and reliable diagnostic tool is urgently needed to support clinical 57 management of patients and to establish the efficacy of heater-cooler unit decontamination 58 procedures. Here we addressed this issue by using comparative genomics to identify DNA 59 sequences present in M. chimaera and absent from other mycobacteria. We describe the initial 60 development and validation of a sensitive, specific and quantitative PCR assay for identification of 61 M. chimaera in both clinical and environmental samples. 62 63 64 test samples. Culture isolation of M. chimaera from 50 mL volumes of water samples was 90 undertaken as described (20) . 91
92
Population structure and phylogenetic analysis. Snippy v3.1 (https://github.com/tseemann/snippy) 93 was used to align Illumina sequence read data or de novo assembled contigs from M. chimaera and 94 related mycobacterial genomes against the fully-assembled, complete MC_ANZ045 reference 95 genome to call core genome single nucleotide polymorphism (SNP) differences and generate 96 pairwise sequence alignments. Hierarchical Bayesian clustering (hierBAPS) was performed using 97 these core whole-genome SNP alignments as input to assess population structure (a prior of 6 depth 98 levels and a maximum of 20 clusters was specified) (21), with phylogenies inferred using FastTree 99 v2.1.8 under a GTR model of nucleotide substitution (22) . Pairwise SNP analysis between groups 100 of genomes was performed using a custom R script (https://github.com/MDU-101 PHL/pairwise_snp_differences). Recombination detection was performed using ClonalFrameML 102 v1.7 (23) . 103
104
In silico subtractive hybridization and target identification. To identify regions of DNA present in 105 M. chimaera but absent from other mycobacteria, the Illumina sequence reads of 46 M. chimaera 106 isolates from Australia and New Zealand and eight publicly available M. intracellulare genomes 107 (Table S1 ) were aligned using BWA MEM v0.7.15-r1140 (https://arxiv.org/abs/1303.3997) to a 108 complete M. chimaera reference genome (MC_ANZ045) (8). The read depth at each position was 109 examined to identify those positions in the reference genome that were present across all 110 M. chimaera isolates but absent from all M. intracellulare genomes. These genomic regions were 111 extracted from MC_ANZ045 and compared against the NCBI Genbank non-redundant (nt) 112 nucleotide database using NCBI BLAST v2.5.0 (CITE?) with parameters -remote -max_target_seqs 113 100 -task blastn -outfmt "6 std qcovs staxid ssciname". Resulting BLAST hits that were missing a 114 taxon name were retrieved from the NCBI taxonomy database using the taxon id. Ignoring BLAST 115 hits against bonafide M. chimaera sequences, the query alignment positions for every hit were 116 extracted and were used to obtain all the sequence segments that had no hits against the Genbank nt 117 database and that were greater than 500 bp in length. For this, bedtools complement and getfasta 118 tools were used (24). The sequence segments thus obtained were considered candidate M. 119 chimaera-specific genomic regions. The presence of these regions across a wider collection of M. 120 chimaera was assessed by downloading all M. chimaera genome sequence reads present in the 121 NCBI sequence read archive SRA as of October 2016 (Table S1 ) and processing through the 122 Nullarbor pipeline v1.2 (https://github.com/tseemann/nullarbor). The output information was used 123 to filter out poor quality or non-M. chimaera reads sets based on G+C content significantly below 124 66%, an average read depth below 30, a total contig length above 8Mb, predicted rRNA genes 125 greater than four, or a total of sequence aligned to the reference genome below 70% (Table S1) . 126
Using Snippy again, all M. chimaera genomes identified above were mapped to a version of the 127 MC_ANZ045 reference genome in which the non-M. chimaera-specific sequence regions had been 128 hard masked. The resulting multiple sequence alignment was parsed using a custom Perl script to 129 identify those M. chimaera-specific regions that were present in all M. chimaera genomes. These 130 DNA sequences were inspected further for development of M. chimaera TaqMan PCR diagnostic 131 assays. TaqMan primers and probes (Sigma Oligonucleotides) were designed using Primer3 (25) 132 and Primer-BLAST against NCBI nt database was used to check that the primers and probes 133 designed were specific to M. chimaera. TaqMan probe 1970-P were labeled with the fluorescent 134 M. chimaera genomes included 49 HCU-associated and 14 previously described patient isolates, 165 not all of which were associated with Stöckert 3T HCU contamination (8, 12). These comparisons 166 identified 448,878 variable nucleotide positions in a 2,340,885 bp core genome. A robust 167 phylogeny inferred from the alignments strongly suggested that M. chimaera forms a monophyletic 168 lineage within the M. intracellulare complex (Fig. 1A) (8, 13) . Bayesian analysis of population 169 structure (BAPS) using these same data confirmed this clustering (Fig. 1A) (Fig. 1A) . We then extended this 177 analysis to assess an additional 257 publicly available M. chimaera and related mycobacterial 178 genome sequences (Table S1 ). Pairwise whole genome comparisons of this larger data set were 179 performed against the ANZ045 reference genome. Population structure analysis indicated 303 180 mycobacterial genomes fell within BAPS-3 (Table S1 ). Pairwise comparisons were again 181 performed against the ANZ045 using only these 303 genomes, with five other genome sequences 182 from BAPS-2 included for context. The alignment was filtered to remove sites from the alignment 183 affected by recombination and a phylogeny was inferred from the resulting 10,166 variable 184 nucleotide positions (Fig. S1. Fig. 2 ). The mean number of SNPs between the 303 genomes was 185 268 (range: 0 -3,211 and IQR: 9 -62). This analysis confirmed that M. chimaera does indeed form 186 a monophyletic lineage, providing a robust genetic definition for the species. As previously 187 reported, HCU-associated isolates from around the world formed a distinct sub-clade within this 188 lineage ( Fig. 2) (8, 13) . 189
190
In silico genome comparisons to identify M. chimaera specific sequences. A subset of 46 genome 191 M. chimaera genome sequences as defined above became the 'training set' to find DNA segments 192 present only in M. chimaera (Fig. 2, Table S1 ). Mapping of DNA sequence reads to the ANZ045 193 reference genome (refer methods) allowed the identification of 159 genomic segments >500 bp in 194 length and covering 510,924 bp that were present across the 46 M. chimaera isolates and absent 195 from eight M. intracellulare isolates (Fig. 1A) . BLAST comparisons of the 159 segments against 196 all entries in the NCBI Genbank nt database and removal of any non-M. chimaera specific 197 sequence reduced the number to 37 segments (covering a total of 37,890 bps). A larger validation 198 set comprising the 63 M. chimaera genomes described in Fig. 1A and 242 additional, publicly 199 available M. chimaera genomes that satisfied our above phylogenomic inclusion criteria was then 200 screened (Table S1 ). Six of the 37 M. chimaera-specific regions (SR), covering a total of 8,292 bp, 201
were present in all 305 M. chimaera genomes (Fig. 1B) . The six SRs ranged in length from 531 bp 202 to 4,641 bp, the majority overlapping predicted chromosomal protein-coding sequences (Fig. 1B,  203 Table 1). Inferred functions of these CDS are summarized (Table 1 ). The regions were scanned for 204 sequence polymorphisms and one of these regions (SR1) that was 100% conserved among all M. 205 chimaera, was selected as a template for the design of a TaqMan assay (Fig. 2, Table 2 ). A pan-bacterial 16S rRNA PCR was first performed to ensure detectable bacterial DNA was 214 present. All 64 DNA samples were positive by 16S rRNA PCR (data not shown) but only the two 215 M. chimaera isolates were 1970-P TaqMan assay positive, supporting the in silico predictions that 216 these assays are specific for M. chimaera (Table S2) . 217
218
TaqMan assay efficiency and sensitivity testing. To establish the limit of detection and 219 amplification efficiency for the 1970-P TaqMan assay, 10-fold serial dilutions of purified 220 M. chimaera ANZ045 genomic DNA were tested in triplicate. The 1970-P assay showed excellent 221 performance characteristics, with a very good linear response across five orders of magnitude, R 2 222 values >0.99, amplification efficiencies of 94%, and a detection limit around 20 genome 223 equivalents (Fig. 3A) . The detection limit was also assessed using dilutions of M. chimaera culture 224 spiked into whole blood. Again, the assay showed excellent performance characteristics in this 225 simulated clinical condition, with an absolute detection limit around 10 CFU (equivalent to 100 226 CFU/mL of blood). These experiments indicate 1970-P is a suitable qPCR assay for sensitive and 227 quantitative detection of M. chimaera DNA. 102,000 GE/mL of water (Table 3) . Using the culture results as a 'gold standard', the negative 238 predictive value for the TaqMan assays was high (100%) with all eight culture positive samples 239 also positive 1970-P TaqMan PCR (Table 4) . However, there was poor correspondence between 240 culture negative samples and qPCR. Fifteen samples negative by culture returned 1970-P TaqMan  241 positive results, with Ct values for some of these samples less than 24, indicating high M. chimaera 242 concentrations above 10,000 GE per milliliter of original sample (Table 3) . Heterotrophic colony 243 count (HCC) at 37ºC is used as a general indicator of water cleanliness, and in some settings may 244 be used as a surrogate indicator of decontamination effectiveness (27). However, we observed a 245 poor correlation between HCC and the presence of M. chimaera as measured by qPCR (Spearman's 246 !=0.2813, p=0.1128) ( Table 3 and are linked to use of a specific type of heater cooler unit (HCU) in the bypass procedure (8, 13, 254 14) . As contamination of these HCUs may have occurred at or near the time of manufacture and 255 the machines are widely exported, exposure to M. chimaera during cardiac bypass surgery is an 256 emerging issue in infection control that is not restricted by region or country (8). However, while it 257 appears that generation of aerosols when machines are contaminated may be relatively common, so 258 far the likelihood of infection for any exposed individual is very low (13). From a clinical 259 perspective, this poses a major diagnostic challenge. Post-cardiac surgery M. chimaera infection 260 has a long incubation period, non-specific symptoms and can be misdiagnosed as a steroid-261 requiring inflammatory condition with potentially disastrous consequences (10, 15) . Moreover, 262 there is a significant case fatality rate even when correctly identified and current opinion is that 263 early accurate diagnosis will be key to achieving the best treatment outcomes (28). Given the non-264 specific symptoms and low prior probability of infection in a large exposed population, The other five M. chimaera-specific regions reported here could be used to develop additional 280 diagnostic targets (Fig. 1B) . We envisage that this test will be used in conjunction with efforts to 281 culture M. chimaera from specimens, as isolates are required for WGS to establish the genetic 282 relatedness of isolates, and potentially for antimicrobial susceptibility testing (although 283 antimicrobial resistance is not thought to be a major problem). As a previous risk assessment by 284 Public Health England suggested a possible legionellosis risk for staff and patients, we propose that 285 our assay should form part of a 'HCU panel' along with Legionella PCR (28, 29). While we have 286 designed an assay to detect all M. chimaera, it may also be possible to detect specific M. chimaera 287 lineages. For instance, it may be possible to use DNA deletion polymorphisms to discriminate 288 among intra-species lineages, as in the Mycobacterium tuberculosis complex (30). We are currently 289 exploring this possibility. 290
291
The infection risk posed by the water reservoirs within HCUs and the need for regular maintenance 292 has been long recognized (29). Heterotrophic colony counts (HCC) are being considered as 293 surrogates to assess the microbiological quality of HCUs (27, 31). We (like others) found a poor 294 correlation between the presence of M. chimaera and HCC in water samples from HCUs (27), with 295 examples of M. chimaera concentrations of 60,000 GE/mL when HCC were below the limit of 296 detection (Table 3 ). More evaluation of the 1970-P assay is required, but our data suggest HCC 297 may have an unacceptably high false-negative rate, which significantly reduces its utility for 298 measuring the effectiveness of HCU decontamination procedures. 299 300 Screening HCU water samples with our TaqMan assay indicated the widespread presence of M. 301 chimaera and a poor correlation with culture. There are several potential explanations for these 302 observations. Despite the extensive in silico assessments, it is possible that the qPCR assay lacks 303 specificity for M. chimaera, or that the culture method lacks sensitivity, or perhaps DNA from M. 304 chimaera is still present but source organisms are no longer viable. Given the extensive in silico 305 validation undertaken here to ensure target specificity, and the high prior probability that these 306 HCU water samples contained M. chimaera, the discrepancy between culture and qPCR might best 307 explained by either lower sensitivity of the mycobacterial culture method or PCR detection of intact 308
DNA from non-viable M. chimaera. The later explanation is perhaps the most likely given that 309 some of these PCR positive-culture negative samples were obtained from HCUs subjected to 310 extensive decontamination procedures involving extended heating above 70ºC. 311 312 In summary, we have developed a new diagnostic tool for rapid, sensitive and specific detection of 313 M. chimaera to help address the urgent need to screen patient and HCU samples. Tables:  450   Table S1 : Mycobacterial genome sequences used in this study 451 
